The UO Institutional Biosafety Committee (IBC) was established by the authority of the university president. The committee was created as a requirement under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guildelines). All work involving recombinant or synthetic nucleic acid molecules must be registered with the IBC. Description of additional types of experiments that must be registered with the IBC are detailed in the committee's Bylaws & Operating Procedures.
UO IBC 2024 meetings are open to the public and held on the third Friday of the month.
The next meeting date is December 6, 2024, via Zoom.
Summary Guide to the NIH Guidelines and PI Responsibilities
Contacts
- Laurie Graham, Laboratory Safety Manager, Biosafety Officer (P) 541-346-2864
Training Review
- NIH Guidelines: Overview
- NIH Guidelines: Safety Considerations
- NIH Guidelines: IBC and Levels of Review
- NIH Guidelines: Responsibilites-Institutional and PI
- NIH Guidelines: Risk Assessment
Process
To register your research, complete the IBC Registration Form before work begins and submit to Laurie Graham.
Please allow several (4-7) weeks prior to anticipated work initiation in order for the committee to provide feedback and approval.